pillbase.ru

Vpriv

Active substance: velaglucerase alfa

velaglucerase alfa

Centralised EU authorisationActive

Marketing holder: Takeda Pharmaceuticals International AG Ireland Branch

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • VPRIV
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · VELAGLUCERASE ALFA 2.5 mg/mL
    54092-701
    Takeda Pharmaceuticals America, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12093-b613-7b1e-93fa-57ddf1659841;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/001249
Registration status
Active
ATC code
A16AB10
Sources
  • product · EMA · EMEA/H/C/001249 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/001249 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/001249 · Verified 2026-10-09